← Back to Search

Lipid Emulsion

experimental group for Very Low Birthweight

N/A
Waitlist Available
Led By Belal Alshaikh, MD,MSc
Research Sponsored by Belal Alshaikh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up until patient regains birth weight, on average within 14 days
Awards & highlights
No Placebo-Only Group

Summary

Provision of high and early fat intake may help to reduce the amount of postnatal weight loss in Very Low Birth Weight Infants. It may also help utilize the high amount of protein that is currently recommended to these premature babies. Also, we expect babies who get this appropriate intake to regain their birth weight earlier than others who are on slow fat increase regimen.

Eligible Conditions
  • Very Low Birthweight

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~until patient regains birth weight, on average within 14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and until patient regains birth weight, on average within 14 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The maximum percentage of weight loss

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: experimental groupExperimental Treatment1 Intervention
The experimental group will begin treatment with 2 g/kg per day of 20% Intravenous Lipid Emulsion after birth. The dose of IVLE will be increased directly from 2 to 3 g/kg per day the next day in this group.
Group II: control groupActive Control1 Intervention
Begins treatment with 0.5 g/kg per day of 20% Intravenous Lipid Emulsion (IVLE) after birth if the birth weight is less or equal 1000g or 1 g/kg per day if birth weight is more than 1000g. The IVLE dose in this group will be increased by 0.5 g/kg per day daily until reaching 3 g/kg per day.

Find a Location

Who is running the clinical trial?

Belal AlshaikhLead Sponsor
3 Previous Clinical Trials
165 Total Patients Enrolled
Belal Alshaikh, MD,MScPrincipal InvestigatorUniversity of Calgary
~12 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top